NCT06069258|RecruitingDMC
Loading search results
Sponsor study identifier
observational
340
1 country
4
Study Start
April 24, 2024
Actual (reported)Primary Completion
December 31, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
December 31, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
This observational study aims to measure movement behaviours and explore factors influencing these among Bahraini patients with type 2 diabetes. The main objectives are: (i) Measure free-living physical activity and sedentary behaviour with an accelerometer device (ii) Examine associations between movement behaviours and anthropometric and diabetes-related biochemical/clinical parameters (iii) Examine associations between movement behaviours and psychological and environmental determinants that influence movement behaviours (iv) Assess the feasibility and acceptability of the physical activity assessment tools as part of routine clinical practice with clinicians and diabetic patients Participants will be invited to wear an accelerometer device for seven days.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 31, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 1, 2023
Actual (reported)October 5, 2023
Actual (reported)April 24, 2024
Actual (reported)December 31, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
December 31, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Movement behaviour
Movement behaviour will be assessed using a thigh-worn accelerometer (activPAL, PAL Technologies, Scotland, U.K. www.palt.com). It has no screen to indicate the amount of physical activity being done, so does not act as a motivational device. The activPAL will be used to collect data 24 hours/day over seven consecutive days.
1 week (duration of the study)
Activity diary
1 week (duration of the study)
Sociodemographic characteristics
Day 1/baseline
Anthropometric parameters
Day 1/baseline
Clinical parameters
Day 1/baseline
Exercise Self-Efficacy
Day 1/baseline and end of study (day 7)
Male and female Bahraini adults aged 20-75 years with controlled type 2 diabetes (i.e. HbA1c \<9 on medication).
Bahraini adults of all ethnicities with controlled diabetes.
Isa Town Health Centre
Building 10, Road 43, Manama, Block 743, Bahrain
Ahmed Ali Kanoo Health Centre
Building 2009, Road 2641, Manama, Block 626, Bahrain
Halat Bu Maher Health Centre
Building 2858, Road 1653, Muharraq, Block 216, Bahrain
Shaikh Jaber AlSabah Health Centre
Ebrahim Rajab, PhD
Royal College of Surgeons in Ireland - Medical University Bahrain
First Submitted
October 1, 2023
First Posted
October 5, 2023
Study Start
April 24, 2024
Actual (reported)Primary Completion
December 31, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
A 12-week Digital Physical Activity Programme, With or Without Physical Education Support for Type 2 Diabetes Patients.
Contact the study team to confirm eligibility.
Building 6347, Road Nakheel Street, Northern Governorate, Block 518, Bahrain
Study Completion
December 31, 2025
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
February 26, 2025
Record last verified: 2025-02
We plan to make available all de-identified IPD that underlies results in the publication.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: